The preclinical pharmacology of the high affinity anti-IL-6R Nanobody? ALX-0061 supports its clinical development in rheumatoid arthritis

IntroductionThe pleiotropic cytokine interleukin-6 (IL-6) plays an important role in the pathogenesis of different diseases, including rheumatoid arthritis (RA). ALX-0061 is a bispecific Nanobody® with a high affinity and potency for IL-6 receptor (IL-6R), combined with an extended half-life by targeting human serum albumin. We describe here the relevant aspects of its in vitro and in vivo pharmacology.MethodsALX-0061 is composed of an affinity-matured IL-6R-targeting domain fused to an albumin-binding domain representing a minimized two-domain structure. A panel of different in vitro assays was used to characterize the biological activities of ALX-0061. The pharmacological properties of ALX-0061 were examined in cynomolgus monkeys, using plasma levels of total soluble (s)IL-6R as pharmacodynamic marker. Therapeutic effect was evaluated in a human IL-6-induced acute phase response model in the same species, and in a collagen-induced arthritis (CIA) model in rhesus monkeys, using tocilizumab as positive control.ResultsALX-0061 was designed to confer the desired pharmacological properties. A 200-fold increase of target affinity was obtained through affinity maturation of the parental domain. The high affinity for sIL-6R (0.19 pM) translated to a concentration-dependent and complete neutralization of sIL-6R in vitro. In cynomolgus monkeys, ALX-0061 showed a dose-dependent and complete inhibition of hIL-6-induced inflammatory parameters, including plasma levels of C-reactive protein (CRP), fibrinogen and platelets. An apparent plasma half-life of 6.6 days was observed after a single intravenous administration of 10 mg/kg ALX-0061 in cynomolgus monkeys, similar to the estimated expected half-life of serum albumin. ALX-0061 and tocilizumab demonstrated a marked decrease in serum CRP levels in a non-human primate CIA model. Clinical effect was confirmed in animals with active drug exposure throughout the study duration.ConclusionsALX-0061 represents a minimized bispecific biotherapeutic of 26 kDa, nearly six times smaller than monoclonal antibodies. High in vitro affinity and potency was demonstrated. Albumin binding as a half-life extension technology resulted in describable and expected pharmacokinetics. Strong IL-6R engagement was shown to translate to in vivo effect in non-human primates, demonstrated via biomarker deregulation as well as clinical effect. Presented results on preclinical pharmacological properties of ALX-0061 are supportive of clinical development in RA.

Electronic supplementary material

The online version of this article (doi:10.1186/s13075-015-0651-0) contains supplementary material, which is available to authorized users.     

Circulating mutant DNA to assess tumor dynamics

The measurement of circulating nucleic acids has transformed the management of chronic viral infections such as HIV. The development of analogous markers for individuals with cancer could similarly enhance the management of their disease. DNA containing somatic mutations is highly tumor specific and thus, in theory, can provide optimum markers. However, the number of circulating mutant gene fragments is small compared to the number of normal circulating DNA fragments, making it difficult to detect and quantify them with the sensitivity required for meaningful clinical use. In this study, we applied a highly sensitive approach to quantify circulating tumor DNA (ctDNA) in 162 plasma samples from 18 subjects undergoing multimodality therapy for colorectal cancer. We found that ctDNA measurements could be used to reliably monitor tumor dynamics in subjects with cancer who were undergoing surgery or chemotherapy. We suggest that this personalized genetic approach could be generally applied to individuals with other types of cancer.     

Down-regulated expression of exocytotic proteins in pancreatic islets of diabetic GK rats

Exocytosis is regulated by exocytotic proteins, which are present in insulin-secreting beta-cells and play regulatory roles in insulin secretion. Non-insulin dependent diabetes mellitus (type 2 diabetes) is a disease characterized by impaired insulin secretion and insulin resistance. Exocytotic protein immunoreactivities were studied in pancreatic islets of type 2 diabetic Goto-Kakizaki (GK) rats using immunofluorescence histochemistry. The immunoreactivities for vesicle-associated membrane protein-2 (VAMP-2), synaptotagmin III, cysteine string protein (CSP), mammalian homologue of the unc-18 gene (Munc-18), alpha-soluble N-ethylmaleimide-sensitive attachment protein (alpha-SNAP), N-ethylmaleimide-sensitive factor (NSF) and synaptosomal-associated protein of 25 kDa (SNAP-25) exhibited weaker immunofluorescence intensity in islets of GK rats as compared to control Wistar rats. Insulin immunoreactivity was also decreased in GK rat beta-cells, whereas no detectable alterations in the expression of actin immunoreactivity could be detected. The data suggest that reduced expression of exocytotic proteins and decreased insulin content may contribute to the diabetic syndrome in the GK rat.     

Predictive Models to Determine Imagery Strategies Employed by Children to Judge Hand Laterality

A commonly used paradigm to study motor imagery is the hand laterality judgment task. The present study aimed to determine which strategies young children employ to successfully perform this task. Children of 5 to 8 years old (N = 92) judged laterality of back and palm view hand pictures in different rotation angles. Response accuracy and response duration were registered. Response durations of the trials with a correct judgment were fitted to a-priori defined predictive sinusoid models, representing different strategies to successfully perform the hand laterality judgment task. The first model predicted systematic changes in response duration as a function of rotation angle of the displayed hand. The second model predicted that response durations are affected by biomechanical constraints of hand rotation. If observed data could be best described by the first model, this would argue for a mental imagery strategy that does not involve motor processes to solve the task. The second model reflects a motor imagery strategy to solve the task. In line with previous research, we showed an age-related increase in response accuracy and decrease in response duration in children. Observed data for both back and palm view showed that motor imagery strategies were used to perform hand laterality judgments, but that not all the children use these strategies (appropriately) at all times. A direct comparison of response duration patterns across age sheds new light on age-related differences in the strategies employed to solve the task. Importantly, the employment of the motor imagery strategy for successful task performance did not change with age.     

Synthesis, Solution Structure, and Phylum Selectivity of a Spider ��-Toxin That Slows Inactivation of Specific Voltage-gated Sodium Channel Subtypes

Magi 4, now renamed δ-hexatoxin-Mg1a, is a 43-residue neurotoxic peptide from the venom of the hexathelid Japanese funnel-web spider (Macrothele gigas) with homology to δ-hexatoxins from Australian funnel-web spiders. It binds with high affinity to receptor site 3 on insect voltage-gated sodium (Na_V) channels but, unlike δ-hexatoxins, does not compete for the related site 3 in rat brain despite being previously shown to be lethal by intracranial injection. To elucidate differences in Na_V channel selectivity, we have undertaken the first characterization of a peptide toxin on a broad range of mammalian and insect Na_V channel subtypes showing that δ-hexatoxin-Mg1a selectively slows channel inactivation of mammalian Na_V1.1, Na_V1.3, and Na_V1.6 but more importantly shows higher affinity for insect Na_V1 (para) channels. Consequently, δ-hexatoxin-Mg1a induces tonic repetitive firing of nerve impulses in insect neurons accompanied by plateau potentials. In addition, we have chemically synthesized and folded δ-hexatoxin-Mg1a, ascertained the bonding pattern of the four disulfides, and determined its three-dimensional solution structure using NMR spectroscopy. Despite modest sequence homology, we show that key residues important for the activity of scorpion α-toxins and δ-hexatoxins are distributed in a topologically similar manner in δ-hexatoxin-Mg1a. However, subtle differences in the toxin surfaces are important for the novel selectivity of δ-hexatoxin-Mg1a for certain mammalian and insect Na_V channel subtypes. As such, δ-hexatoxin-Mg1a provides us with a specific tool with which to study channel structure and function and determinants for phylum- and tissue-specific activity.Voltage-gated sodium (Na_V)⁴ channels are responsible for the generation and propagation of electrical signals in excitable cells. At least nine different genes encoding distinct Na_V channels isoforms have been identified, and functionally expressed, in mammals (1). They are characterized by their sensitivity to TTX, with Na_V1.5, Na_V1.8, and Na_V1.9 being TTX-insensitive or TTX-resistant, and the remaining subtypes being sensitive to nanomolar concentrations of TTX. In addition, localization of the subtypes also varies, with Na_V1.1–1.3 mostly distributed in the central nervous system, Na_V1.6–1.9 principally located in the peripheral nervous system, and Na_V1.4 and Na_V1.5 found in skeletal and cardiac muscle, respectively. The structural diversity of Na_V channels also coincides with variations in physiological and pharmacological properties (2). In contrast, insects express only one gene (para) that undergoes extensive alternative splicing and RNA editing (3). The para-encoded Na_V channel is exceptionally well conserved across diverse orders of insects, with the level of identity ranging from 87 to 98% (3). This is one reason why insecticides that target insect Na_V channels have broad activity across many insect orders. In contrast, para-type Na_V channels have significantly lower levels of identity with the various types of mammalian Na_V channels with the level of identity typically around 50–60% (3). This explains why a high degree of phylogenetic specificity can be achieved with both Na_V channel toxins and insecticides that target the Na_V channel.At least seven distinct toxin-binding sites have been identified by radioligand binding and electrophysiological studies on vertebrate and insect Na_V channels (4, 5). Toxins interacting with these neurotoxin receptor sites have been instrumental in the study of Na_V channel topology, function, and pharmacology (6). In particular, a wide range of scorpion α-toxins, sea anemone toxins, and spider δ-hexatoxins (formerly δ-atracotoxins (7)) compete for binding to receptor site-3 on the extracellular surface of Na_V channels. These polypeptide toxins all inhibit the fast inactivation of Na_V channels to prolong Na⁺ currents (I_Na), despite huge diversity in primary and tertiary structures (8, 9). Nevertheless, receptor site-3 has not yet been fully characterized but is believed to involve domains DI/S5-S6, DIV/S5-S6, as well as DIV/S3-S4 (9). Most importantly, however, toxin characterization is often limited to studies using whole-cell I_Na or binding studies on neuronal membranes where there are mixed populations of Na_V channel subtypes. For all of these toxins, the precise pattern of Na_V channel subtype selectivity is either unknown or at best is incomplete.Recently, it was found that receptor site-3 was also recognized by a 43-residue spider toxin, originally named Magi 4, from the hexathelid spider Macrothele gigas (Iriomote, Japan). It binds with high affinity to insect Na_V channels but, similar to scorpion α-like toxins, does not compete for the related site-3 in rat brain synaptosomes, despite being lethal by intracranial injection (10). Magi 4 shares significant homology to four δ-hexatoxin (HXTX)-1 family peptides and δ-actinopoditoxin-Mb1a (formerly δ-missulenatoxin-Mb1a; Fig. 1) but no sequence homology to scorpion α-toxins. Neurochemical studies have shown that δ-HXTX-1 toxins compete at nanomolar concentrations with both anti-mammalian (e.g. Aah2 and Lqh2) and anti-insect (e.g. LqhαIT) scorpion toxins for site-3 (11–13). The three-dimensional structures of δ-HXTX-Ar1a and δ-HXTX-Hv1a peptides have been determined (14, 15) and possess core β regions stabilized by four disulfide bonds, placing them in the inhibitory cystine knot (ICK) structural family (16).Open in a separate windowFIGURE 1.Primary and secondary structure of δ-HXTX-Mg1a. A, comparison of the primary sequence of δ-HXTX-Mg1a and δ-HXTX-Mg1b (formerly Magi 14) with currently known members of the δ-HXTX-1 family and δ-AOTX-Mb1a (δ-actinopoditoxin-Mb1a, formerly δ-missulenatoxin-Mb1a). Homologies are shown relative to δ-HXTX-Mg1a; identities are boxed in gray, and conservative substitutions are in gray italic text. Gaps (dashes) have been inserted to maximize alignment. The disulfide bonding pattern for the strictly conserved cysteine residues determined for δ-HXTX-Mg1a (this study), δ-HXTX-Ar1a (55), and δ-HXTX-Hv1a (15) is indicated above the sequences; it is assumed that δ-AOTX-Mb1a (36), δ-HXTX-Hs20.1a (8), and δ-HXTX-Hv1b (56) have the same disulfide bonding pattern. The percentage identity and homology with δ-HXTX-Mg1a is shown to the right of the sequences. B, summary of δ-HXTX-Mg1a NMR data. Sequential NOEs, classified as very weak, weak, medium, and strong, are represented by the thickness of bars. Filled diamonds indicate backbone amide protons that form hydrogen bonds. ³J_NHCα coupling constants are indicated by ↑ (>8 Hz) and ↓ (<5.5 Hz). Secondary structure is shown at the bottom of the figure where rectangles represent β-turns (the type of turn is indicated in the rectangle) and arrows represent β-sheets.The aim of this study was to first determine the solution structure of Magi 4 and second to investigate the ability of Magi 4 to discriminate between different Na_V channels subtypes. Here we report the tertiary structure of Magi 4 by ¹H NMR and show its disulfide bonding pattern and three-dimensional structure are homologous to δ-HXTX-1 toxins. We highlight the key residues in Magi 4 that appear to be topologically similar to those residues known to be part of the pharmacophore for site-3 scorpion α-toxins, despite Magi 4 having a different overall structure to scorpion α-toxins (11). In addition, we provide a detailed characterization of the selectivity and mode of action of Magi 4 on nine cloned mammalian and insect Na_V channel subtypes, including a detailed characterization on insect neurotransmission. Given that the toxin potently slows the inactivation of Na_V channels, it should be renamed δ-hexatoxin-Mg1a (δ-HXTX-Mg1a) in accordance with the rational nomenclature recently proposed for naming spider peptide toxins (7) (see ArachnoServer spider toxin data base).     

A new species of Pliopithecus Gervais, 1849 (Primates: Pliopithecidae) from the Middle Miocene (MN8) of Abocador de Can Mata (els Hostalets de Pierola,Catalonia, Spain)

Pliopithecus (Pliopithecus) canmatensis sp. nov. is described from several Late Aragonian localities from Abocador de Can Mata (ACM) in els Hostalets de Pierola (Vallès‐Penedès Basin, Catalonia, Spain), spanning from ～11.7 to 11.6 Ma (C5r.3r subchron), and being correlated to the MN8 (reference locality La Grive L3). The ACM remains display a pliopithecine dental morphology with well‐developed pliopithecine triangles on M/2 and M/3. This, together with other occlusal details, negates an attribution to the subgenus Epipliopithecus. Although slightly smaller, the ACM remains are most similar in size to comparable elements of P. piveteaui and P. antiquus. Several occlusal details (such as the greater development of the buccal cingulid in lower molars) and dental proportions (M/3 much longer than M/2), however, indicate greater similarities with P. antiquus from Sansan and La Grive. The ACM remains, however, differ from P. antiquus in dental proportions as well as occlusal morphology of the lower molars (including the less peripheral position of the protoconid and more medial position of the hypoconulid, the more mesial position of the buccal cuspids as compared to the lingual ones, the narrower but distinct mesial fovea, the higher trigonid, and the more extensive buccal cingulid, among others). These differences justify a taxonomic distinction at the species level of the ACM pliopithecid remains with respect to P. antiquus. Previous pliopithecid findings from the Vallès‐Penedès Basin, previously attributed to P. antiquus, are neither attributable to the latter species nor to the newly erected one. Am J Phys Anthropol, 2010. © 2009 Wiley‐Liss, Inc.     

Expression of biologically active mouse ciliary neutrophic factor (CNTF) and soluble CNTFRalpha in Escherichia coli and characterization of their functional specificities

Ciliary neurotrophic factor (CNTF) is a neuroprotective cytokine initially identified in chick embryo. It has been evaluated for the treatment of neurodegenerative diseases. CNTF also acts on non-neuronal cells such as oligodendrocytes, astrocytes, adipocytes and skeletal muscles cells. CNTF has regulatory effects on body weight and is currently in clinical trial for the treatment of diabetes and obesity. CNTF mediates its function by activating a tripartite receptor comprising the CNTF receptor alpha chain (CNTFRalpha), the leukemia inhibitory factor receptor beta chain (LIFRbeta) and gp130. Human, rat and chicken CNTF have been expressed as recombinant proteins, and most preclinical studies in murine models have been performed using rat recombinant protein. Rat and human CNTF differ in their fine specificities: in addition to CNTFR, rat CNTF has been shown to activate the LIFR (a heterodimer of LIFRbeta and gp130), whereas human CNTF can bind and activate a tripartite receptor comprising the IL-6 receptor alpha chain (IL-6Ralpha) and LIFR. To generate tools designed for mouse models of human diseases; we cloned and expressed in E. coli both mouse CNTF and the CNTFRalpha chain. Recombinant mouse CNTF was active and showed a high level of specificity for mouse CNTFR. It shares the arginine residue with rat CNTF which prevents binding to IL-6Ralpha. It did not activate the LIFR at all concentrations tested. Recombinant mouse CNTF is therefore specific for CNTFR and as such represents a useful tool with which to study CNTF in mouse models. It appears well suited for the comparative evaluation of CNTF and the two additional recently discovered CNTFR ligands, cardiotrophin-like cytokine\cytokine-like factor-1 and neuropoietin.     

Blood Parasite Infection Intensity Covaries with Risk‐Taking Personality in Male Carpetan Rock Lizards (Iberolacerta cyreni)

Identifying evolutionary and developmental mechanisms underlying consistent between‐individual differences in behaviour is the main goal in ‘animal personality studies’. Here, we explored whether activity and risk‐taking varied consistently between individuals and correlated to various – potentially fitness linked – male traits in Carpetan rock lizards (Iberolacerta cyreni). Lizards showed significant consistency within both behaviours, implying the presence of activity and risk‐taking personalities. However, there were no correlation between activity and risk‐taking, neither on the between‐ nor on the within‐individual levels, implying the absence of a behavioural syndrome. We found a strong link between the intensity of blood parasite (Haemogregarinidae) infection and risk‐taking: lizards with higher infection intensity took more risk. While we cannot distinguish cause from causative in the parasite intensity – risk‐taking correlation – our results are in line with the asset protection hypothesis predicting that individuals with lower future reproductive value should focus on the current reproductive event and take higher risk.     

Phosphorylation regulates the activity of the SMN complex during assembly of spliceosomal U snRNPs

The assembly of spliceosomal U-rich small nuclear ribonucleoproteins (U snRNPs) is an ATP-dependent process mediated by the coordinated action of the SMN and the PRMT5 complex. Here, we provide evidence that the activity of this assembly machinery is regulated by means of post-translational modification. We show that two main components of the SMN/PRMT5 system, namely the survival motor neuron (SMN) protein (reduced levels thereof causing spinal muscular atrophy) and pICln, are phosphorylated in vivo. Both proteins share a previously unknown motif containing either one or two phosphoserines. Alteration of these residues in SMN (serines 28 and 31) significantly impairs the activity of the SMN complex. Despite the presence of SMN in both the nucleus and cytoplasm, we find that only the latter promotes efficient SMN-mediated U snRNP assembly activity. As cytoplasmic SMN is phosphorylated to a much larger extent, we hypothesize that this modification is a key activator of the SMN complex.